Enliven Therapeutics Inc
XNAS: ELVN
Enliven Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product...
Read More
19.19
0.00
(0.00%)
51
XNAS Volume
XNAS 24 Sep, 2025 9:21 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Enliven Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..